98 related articles for article (PubMed ID: 33131967)
1. Correction to: YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
Toxicol In Vitro; 2021 Apr; 72():105033. PubMed ID: 33131967
[No Abstract] [Full Text] [Related]
2. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
[TBL] [Abstract][Full Text] [Related]
3. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose.
Gao M; Yang Y; Gao Y; Liu T; Guan Q; Zhou T; Shi Y; Hao M; Li Z; Zuo D; Zhang W; Wu Y
Chem Biol Interact; 2022 Feb; 354():109843. PubMed ID: 35122754
[TBL] [Abstract][Full Text] [Related]
4. MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells.
Du J; Li J; Gao M; Guan Q; Liu T; Wu Y; Li Z; Zuo D; Zhang W; Wu Y
Chem Biol Interact; 2020 May; 323():109074. PubMed ID: 32217108
[TBL] [Abstract][Full Text] [Related]
5. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
6. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
7. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.
Gonçalves A; Braguer D; Kamath K; Martello L; Briand C; Horwitz S; Wilson L; Jordan MA
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11737-42. PubMed ID: 11562465
[TBL] [Abstract][Full Text] [Related]
8. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.
Bai Z; Gao M; Xu X; Zhang H; Xu J; Guan Q; Wang Q; Du J; Li Z; Zuo D; Zhang W; Wu Y
Cell Prolif; 2018 Aug; 51(4):e12450. PubMed ID: 29493085
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.
Yang CP; Horwitz SB
Biochim Biophys Acta; 2002 Jun; 1590(1-3):76-83. PubMed ID: 12063170
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM
Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525
[TBL] [Abstract][Full Text] [Related]
11. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.
Qu Z; Zou X; Zhang X; Sheng J; Wang Y; Wang J; Wang C; Ji Y
Mol Med Rep; 2016 Feb; 13(2):1336-44. PubMed ID: 26677104
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
Yang CP; Galbiati F; Volonte D; Horwitz SB; Lisanti MP
FEBS Lett; 1998 Nov; 439(3):368-72. PubMed ID: 9845355
[TBL] [Abstract][Full Text] [Related]
14. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
Zhou J; O'brate A; Zelnak A; Giannakakou P
Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
[TBL] [Abstract][Full Text] [Related]
15. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors.
Aronica E; Gorter JA; Jansen GH; van Veelen CW; van Rijen PC; Leenstra S; Ramkema M; Scheffer GL; Scheper RJ; Troost D
Neuroscience; 2003; 118(2):417-29. PubMed ID: 12699778
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen JG; Yang CP; Cammer M; Horwitz SB
Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
[TBL] [Abstract][Full Text] [Related]
18. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line.
Perloff MD; Von Moltke LL; Marchand JE; Greenblatt DJ
J Pharm Sci; 2001 Nov; 90(11):1829-37. PubMed ID: 11745741
[TBL] [Abstract][Full Text] [Related]
19. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
Ji L; Liu X; Zhang S; Tang S; Yang S; Li S; Qi X; Yu S; Lu L; Meng X; Liu Z
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072615
[TBL] [Abstract][Full Text] [Related]
20. RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.
Shao SL; Cui TT; Zhao W; Zhang WW; Xie ZL; Wang CH; Jia HS; Liu Q
Asian Pac J Cancer Prev; 2014; 15(24):10597-601. PubMed ID: 25605145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]